Clinical Trials Logo

Clinical Trial Summary

To assess the efficacy of skin tests with platinum salts in patients suspects with immediate hypersensitivity reactions. All patients adressed in consultation to the Allergy Department of university hospital of nancy for an immediate hypersensitivity reaction to platinum salts between 2015 and 2021 were retrospectively recruited.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04920721
Study type Observational
Source Central Hospital, Nancy, France
Contact Tania ADAM, Dr
Email t.adam@chru-nancy.fr
Status Recruiting
Phase
Start date June 2021
Completion date July 2021

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT06414694 - Inpatient Penicillin Delabeling for Low-Risk Patients Phase 4
Completed NCT05706246 - Perioperative Hypersensitivity in Children N/A
Completed NCT02118987 - Study of Omalizumab as Adjuvant Therapy in Chemotherapy Desensitization Phase 1
Enrolling by invitation NCT03164044 - Improved Basophil Activation Test (BAT) in the Diagnostics of Drug Allergy
Completed NCT02094638 - Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study N/A
Not yet recruiting NCT06399601 - A Training Program of Drug Allergy for Healthcare Professionals N/A
Completed NCT03784482 - Multiple Drug Hypersensitivity Syndrome
Not yet recruiting NCT06406114 - Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing Phase 2
Recruiting NCT05820802 - High Dimensional Analysis of Immune Cells in Pediatric Patients